Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Hoxer CS"'
Publikováno v:
In Value in Health October-November 2017 20(9):A559-A559
Autor:
Rtveladze, K1, Hoxer, CS2
Publikováno v:
Value in Health. Oct2017, Vol. 20 Issue 9, pA477-A477. 1p.
Autor:
McMeekin P; Health Economics and Health Technology Assessment, Institute of Health & Wellbeing, University of Glasgow, UK.; Northumbria University, Faculty of Health and Life Sciences, Newcastle, UK., Geue C; Health Economics and Health Technology Assessment, Institute of Health & Wellbeing, University of Glasgow, UK., Mocevic E; Novo Nordisk A/S., Søborg, Denmark., Hoxer CS; Novo Nordisk Ltd., West Sussex, UK., Ochs A; MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK., McGurnaghan S; MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK., Colhoun HM; MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK., Wild SH; Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK., Wu O; Health Economics and Health Technology Assessment, Institute of Health & Wellbeing, University of Glasgow, UK.
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association [Diabet Med] 2020 Nov; Vol. 37 (11), pp. 1927-1934. Date of Electronic Publication: 2020 Feb 14.
Autor:
Viljoen A; Borthwick Diabetes Research Centre, Lister Hospital (East and North Hertfordshire NHS Trust), Stevenage, UK., Hoxer CS; Novo Nordisk Ltd, Gatwick, UK., Johansen P; Novo Nordisk A/S, Søborg, Denmark., Malkin S; Ossian Health Economics and Communications, Basel, Switzerland., Hunt B; Ossian Health Economics and Communications, Basel, Switzerland., Bain SC; Swansea University Medical School, Swansea, UK.
Publikováno v:
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2019 Mar; Vol. 21 (3), pp. 611-621. Date of Electronic Publication: 2018 Nov 28.
Autor:
Hoxer CS; Novo Nordisk Ltd., Gatwick, UK., Zak M; Novo Nordisk A/S, Søborg, Denmark., Benmedjahed K; Patient-Centered Outcomes, Mapi, an ICON plc Company, Lyon, France., Lambert J; Patient-Centered Outcomes, Mapi, an ICON plc Company, Lyon, France.
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2019 Jan; Vol. 25 (1), pp. 92-100. Date of Electronic Publication: 2018 Nov 21.
Autor:
Barnett AH; Heart of England NHS Foundation Trust and University of Birmingham, Birmingham, UK., Arnoldini S; Ossian Health Economics and Communications, Basel, Switzerland., Hunt B; Ossian Health Economics and Communications, Basel, Switzerland., Subramanian G; Novo Nordisk Ltd, UK., Hoxer CS; Novo Nordisk Ltd, UK.
Publikováno v:
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2018 Aug; Vol. 20 (8), pp. 1921-1927. Date of Electronic Publication: 2018 May 03.
Autor:
Keep MV; BresMed Netherlands BV, Arthur van Schendelstraat 650, 3511MJ Utrecht, The Netherlands., Hoxer CS; Novo Nordisk A/S, Vandtårnsvej 114, DK-2860 Søborg, Denmark., Hemstock M; BresMed Health Solutions, Ltd, North Church House, 84 Queen Street, Sheffield S1 2DW, UK., Groth AV; Novo Nordisk A/S, Vandtårnsvej 114, DK-2860 Søborg, Denmark., Knight C; RTI Health Solutions (Formerly BresMed Health Solutions, Ltd), The Pavilion, Towers Business Park, Wilmslow Road, Didsbury, Manchester M20 2LS, UK.
Publikováno v:
Journal of comparative effectiveness research [J Comp Eff Res] 2018 Jan; Vol. 7 (1), pp. 39-48. Date of Electronic Publication: 2017 May 30.
Autor:
Neufeld EJ; St. Jude Children's Research Hospital, Memphis, USA., Solimeno L; IRCCS Cà Granda Foundation, Maggiore Hospital, Milan, Italy., Quon D; Orthopaedic Hemophilia Treatment Center, Los Angeles, USA., Walsh C; Mount Sinai Hospital, New York, USA., Seremetis S; Novo Nordisk A/S, Plainsboro, USA., Cooper D; Novo Nordisk A/S, Plainsboro, USA., Iyer NN; Novo Nordisk A/S, Plainsboro, USA., Hoxer CS; Novo Nordisk A/S, Søborg, Denmark., Giangrande P; Oxford University Hospitals NHS Trust, Oxford Haemophilia Centre, Oxford, UK.
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2017 Nov; Vol. 23 (6), pp. 821-831. Date of Electronic Publication: 2017 Jul 27.
Autor:
Carcao M; Division of Haematology/Oncology, Department of Paediatrics, Child Health Evaluative Sciences, Research Institute, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada., Kearney S; CHCMN Hemophilia and Thrombosis Center Children's Hospital and Clinics of Minnesota, Minneapolis, MN, USA., Santagostino E; Angelo Bianchi Bonomi Hemophilia and Thrombosis Centre, Istituto di Ricovero e Cura a Carattere Scientifico Cà Granda Foundation, Maggiore Hospital Policlinico, Milan, Italy., Oyesiku JOO; Department of Haemophilia, Haemostasis and Thrombosis, Hampshire Hospitals NHS Foundation Trust, Basingstoke, Hampshire, UK., Young NL; School of Rural and Northern Health and ECHO Research Centre, Laurentian University, Sudbury, ON, Canada., Meunier J; Mapi, Patient-Centered Outcomes, Lyon, France., Hoxer CS; Novo Nordisk A/S, Søborg, Denmark., Zhang C; Division of Haematology/Oncology, Department of Paediatrics, Child Health Evaluative Sciences, Research Institute, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada., Blanchette VS; Division of Haematology/Oncology, Department of Paediatrics, Child Health Evaluative Sciences, Research Institute, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2017 May; Vol. 23 (3), pp. e222-e224. Date of Electronic Publication: 2017 Mar 30.